Alhambra Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Alhambra Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$414K	Buy	7,185 +117	+2%	+$6.72K	0.18%	111
2026 Q1	$429K	Sell	7,068 -42	-0.6%	-$2.45K	0.2%	107
2025 Q4	$383K	Sell	7,110 -117	-2%	-$5.63K	0.18%	116
2025 Q3	$326K	Sell	7,227 -1,570	-18%	-$73.3K	0.15%	127
2025 Q2	$407K	Buy	8,797 +1,849	+27%	+$90.8K	0.2%	110
2025 Q1	$424K	Sell	6,948 -281	-4%	-$16.4K	0.22%	102
2024 Q4	$409K	Sell	7,229 -22	-0.3%	-$1.23K	0.21%	104
2024 Q3	$375K	Sell	7,251 -1,562	-18%	-$73.3K	0.19%	120
2024 Q2	$366K	Sell	8,813 -9,175	-51%	-$411K	0.2%	110
2024 Q1	$976K	Sell	17,988 -7,135	-28%	-$363K	0.53%	45
2023 Q4	$1.29M	Sell	25,123 -388	-2%	-$20.4K	0.77%	34
2023 Q3	$1.48M	Buy	25,511 +401	+2%	+$24.6K	0.97%	27
2023 Q2	$1.61M	Buy	25,110 +95	+0.4%	+$6.37K	1.06%	25
2023 Q1	$1.73M	Buy	25,015 +751	+3%	+$53K	1.19%	21
2022 Q4	$1.75M	Sell	24,264 -855	-3%	-$64.5K	1.27%	16
2022 Q3	$1.79M	Buy	25,119 +437	+2%	+$31.7K	1.36%	14
2022 Q2	$1.9M	Sell	24,682 -399	-2%	-$30.4K	1.37%	13
2022 Q1	$1.83M	Sell	25,081 -891	-3%	-$59.8K	1.21%	14
2021 Q4	$1.62M	Buy	25,972 +2,249	+9%	+$132K	1.13%	22
2021 Q3	$1.4M	Buy	23,723 +1,194	+5%	+$78.6K	1.07%	24
2021 Q2	$1.5M	Buy	22,529 +605	+3%	+$39.4K	1.13%	16
2021 Q1	$1.38M	Buy	21,924 +1,364	+7%	+$84.9K	1.12%	20
2020 Q4	$1.27M	Buy	20,560 +365	+2%	+$22.4K	1.36%	14
2020 Q3	$1.22M	Buy	20,195 +2,827	+16%	+$170K	1.46%	14
2020 Q2	$1.02M	Sell	17,368 -248	-1%	-$14.8K	1.34%	16
2020 Q1	$982K	Sell	17,616 -876	-5%	-$53.5K	1.61%	14
2019 Q4	$1.19M	Buy	+18,492	New	+$1.06M	1.37%	17

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Alhambra Investment Management's BMY Position: Q2 2026 in Review

Alhambra Investment Management increased its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, buying an estimated $6.72K and bringing the position to 7,185 shares worth $414K. The position accounts for 0.18% of the portfolio, ranked #111.

Alhambra Investment Management first reported a position in BMY in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.9M in Q2 2022. 1,096 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Alhambra Investment Management held 7,185 shares of Bristol-Myers Squibb worth $414K as of Q2 2026.
Alhambra Investment Management bought 117 Bristol-Myers Squibb shares in Q2 2026, an estimated $6.72K.
Bristol-Myers Squibb made up 0.18% of Alhambra Investment Management's portfolio in Q2 2026, its #111 holding.
Alhambra Investment Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 27 quarters since.
Alhambra Investment Management's Bristol-Myers Squibb position peaked at $1.9M in Q2 2022.
1,096 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Alhambra Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.